Pharmacological and chemical properties of astressin, antisauvagine-30 and alpha-helCRF: significance for behavioral experiments. (Q51063137)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11543771%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Pharmacological and chemical properties of astressin, antisauvagine-30 and alpha-helCRF: significance for behavioral experiments (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11543771%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11543771%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

O Brauns

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11543771%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

T Liepold

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11543771%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

J Spiess

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11543771%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 September 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11543771%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

Neuropharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11543771%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11543771%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11543771%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

507-516

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11543771%20AND%20SRC:MED&resulttype=core&format=json

The role of corticotropin-releasing factor in depression and anxiety disorders

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900094-6

Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900094-6

Corticotrophin-releasing factor receptors: from molecular biology to drug design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900094-6

Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900094-6

Corticotropin-releasing factor receptors: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900094-6

Sauvagine, a new polypeptide from Phyllomedusa sauvagei skin. Occurrence in various Phyllomedusa species and pharmacological actions on rat blood pressure and diuresis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900094-6

Differential Antagonist Activity ofα-Helical Corticotropin-Releasing Factor9–41in Three Bioassay Systems*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900094-6

Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900094-6

125I-Antisauvagine-30: a novel and specific high-affinity radioligand for the characterization of corticotropin-releasing factor type 2 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900094-6

How we describe competitive antagonists: three questions of usage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900094-6

Differences between natural and recombinant G protein-coupled receptor systems with varying receptor/G protein stoichiometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900094-6

Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900094-6

Distribution of urocortin-like immunoreactivity in the central nervous system of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900094-6

Hydrogen ions kill brain at concentrations reached in ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900094-6

Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900094-6

Astressin, a novel and potent CRF antagonist, is neuroprotective in the hippocampus when administered after a seizure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900094-6

Constrained corticotropin-releasing factor antagonists with i-(i + 3) Glu-Lys bridges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900094-6

The distribution of corticotropin releasing factor-like immunoreactive neurons in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900094-6

Corticotropin-releasing factor binding to the anterior pituitary receptor is modulated by divalent cations and guanyl nucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900094-6

The first extracellular domain of corticotropin releasing factor-R1 contains major binding determinants for urocortin and astressin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900094-6

Light and electron microscopic evaluation of hydrogen ion-induced brain necrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900094-6

Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900094-6

Synthetic Competitive Antagonists of Corticotropin-Releasing Factor: Effect on ACTH Secretion in the Rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900094-6

High-affinity binding of urocortin and astressin but not CRF to G protein-uncoupled CRFR1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900094-6

Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900094-6

Synthesis and characterization of a photoactivatable analog of corticotropin-releasing factor for specific receptor labeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900094-6

pA, a new scale for the measurement of drug antagonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900094-6

Characterisation using microphysiometry of CRF receptor pharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900094-6

Primary structure of corticotropin-releasing factor from ovine hypothalamus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900094-6

Behavioral effects of central administration of the novel CRF antagonist astressin in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900094-6

Corticotropin releasing factor produces behavioural activation in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900094-6

Structure-function relationship of different domains of the rat corticotropin-releasing factor receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900094-6

Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900094-6

Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900094-6

How should values of pA2 and affinity constants for pharmacological competitive antagonists be estimated?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900094-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0028-3908(01)00094-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11543771%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference